News

New findings from CUSTOMIZE suggest the once-monthly injection therapy was feasibly implemented and generally favored to once-daily tablets.

Perspective gained from persons treated a real-world clinic may help better inform strategies to treat an HIV population that often struggles with viral suppression and consistent care.

A new study from IAS 2021 suggests persons with HIV hospitalized for COVID-19 do not face worse mortality nor major cardiovascular event risk.

Results from the study highlight the importance of PrEP education in clinical settings.

The prophylaxis showed non-inferiority across shared serotypes with an available 13-valent vaccine in its indication-supporting data.

The designation moves the companies' PDUFA date up to January 2022, when BNT162b2 may become the first regulated COVID-19 vaccine.

As younger generations come of age, there is a continuous need to inform them about HIV risks, offer insights about prevention strategies, and understand the challenges for people living with HIV (PLWH).

94% of the participants developed IgG antibodies against the virus 3 weeks after administration.

Truncated ACE2 levels served to discriminate patients infected with SARS-CoV-2 and influenza A.

A large study finds 1 out of 2 patients develop at least one during their hospital stay.

The HPV vaccine is incredibly important in preventing certain cancers and a new study sought to address the safety concerns for vaccine refusal in a national immunization survey for teenagers.

The Johnson & Johnson vaccine showed neutralizing antibody responses against variants of concern.

PrEP use is estimated to prevent >90% of infections in men who have sex with men and 70% of infections in people who inject drugs.

Before other states adopt randomly-selected payouts for COVID-19 vaccine administration, further research is needed into these lotteries’ effects on potential increases in vaccination rates.

The MOVe-OUT study will continue to the phase 3 portion and evaluate 800 mg of the therapy administered twice daily.

With vaccine uptake slowing, any information that can help is needed to increase administration.

Genetic changes enable SARS-CoV-2 to enter the body, replicate and trigger out-of-control immune responses.

A recent press briefing by the Infectious Diseases Society of America (IDSA) addressed the need to have new antibiotics in the pipeline to answer the rising challenge of drug resistance.

A group of personnel at a veterans administration medical center (VAMC)) did a drive-thru to help bolster vaccination amongst coworkers.

The biosensor detects fragments of the SARS-CoV-2 virus as well as variants.

Understanding how future waves will impact areas can help officials implement policies to mitigate them.

Those taking methotrexate had lower seroconversion rates compared to controls.

Providing "social normative feedback" to physicians succeeded in lowering antibiotic treatment duration and cost, with less effect on prescription volume.

A meeting between developers and federal experts was inconclusive to the necessity of a third mRNA dose for COVID-19.

The CDC announced 100 preliminary cases of Guillain-Barré syndrome following vaccine administration.

While infection risk is not eliminated, the vaccine still provided significant protection.

The second wave in South Africa was larger and saw the Beta lineage dominate.

Investigators followed patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) for 6 months to review their outcomes.